跳至主要内容
临床试验/NCT06503939
NCT06503939Enrolling By Invitation不适用

Etiology Analysis of Chronic Cough After COVID-19 Infection and Research on the Efficacy of ICS or ICS/LABA

Xiangya Hospital of Central South University1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2023年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
600
试验地点
1
主要终点
The etiology of chronic cough was comprehensively analyzed and classified.

研究概览

简要总结

This study collected 600 patients, evaluated whether patients had airway hyperreactivity, airway inflammation, specific types and allergic reactions, comprehensively analyzed and classified the causes of chronic cough in patients, and evaluated and compared the improvement of cough symptoms and quality of life after ICS or ICS/LABA treatment.

详细描述

The subjects of this study were patients with chronic cough who were admitted to the Department of Respiratory and Critical Care Medicine, Xiangya Hospital, Central South University from September 1, 2023 to December 31, 2024. Patients are registered if they meet all of the following criteria: (1) ≥18 years of age; (2) A clear history of COVID-19 infection with a positive nucleic acid or antigen test before chronic cough;(3) Persistent cough for more than 8 weeks after the acute phase of COVID-19 infection has disappeared; (4) Chest X-ray and/or chest CT without significant evidence of lung disease; (5) No history of chronic cough (>8 weeks) prior to COVID-19 infection. Patients who met any of the following criteria were excluded: (1) Patients refused pulmonary function, blood tests; (2) The patient has previously been diagnosed with respiratory diseases with cough as one of the main symptoms, including cough variant asthma, allergic bronchitis, eosinophilic bronchitis, gastroesophageal reflux disease, chronic obstructive pulmonary disease, chronic bronchitis, bronchiectasis, interstitial lung disease, pulmonary/tracheobronchial tuberculosis, etc.; (3) Patients who are pregnant or breastfeeding; (4) The patient's medical records are incomplete; (5) Patients lost to follow-up.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥18 years old;
  • A clear history of COVID-19 infection with a positive nucleic acid or antigen test before chronic cough;
  • Persistent cough for more than 8 weeks after the acute phase of COVID-19 infection has disappeared;
  • Chest X-ray and/or chest CT without significant evidence of lung disease;
  • No history of chronic cough (>8 weeks) prior to COVID-19 infection.

排除标准

  • The patient refused pulmonary function and blood tests;
  • The patient has previously been diagnosed with respiratory diseases with cough as one of the main symptoms, including cough variant asthma, allergic bronchitis, eosinophilic bronchitis, gastroesophageal reflux disease, chronic obstructive pulmonary disease, chronic bronchitis, bronchiectasis, interstitial lung disease, pulmonary/tracheobronchial tuberculosis, etc.;
  • Patients who are pregnant or breastfeeding;
  • The patient's medical records are incomplete;
  • Patients lost to follow-up.

结局指标

主要结局

The etiology of chronic cough was comprehensively analyzed and classified.

时间窗: 2023.09-2024.12

次要结局

  • To evaluate and compare cough symptoms and quality of life improvement after ICS or ICS/LABA treatment.(2023.09-2024.12)

研究者

发起方
Xiangya Hospital of Central South University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验